Review – Treatment of Helicobacter pylori infection
Helicobacter pylori continues to present therapeutic challenges for clinicians across the world. This review article aims to consolidate current knowledge of H. pylori infection with a particular emphasis on treatment strategy and summarizes important studies regarding H. pylori therapy published fr...
Main Authors: | V. Milivojevic, T. Milosavljevic |
---|---|
Format: | Article |
Language: | English |
Published: |
Verduci Editore
2021-08-01
|
Series: | Microbiota in Health and Disease |
Subjects: | |
Online Access: | https://www.microbiotajournal.com/wp-content/uploads/sites/7/2021/08/e525.pdf |
Similar Items
-
14-Day Vonoprazan-Based Bismuth Quadruple Therapy for Treatment-Naïve Patients with Helicobacter pylori Infection: A Retrospective Comparative Study
by: Lu F, et al.
Published: (2023-09-01) -
Treatment of <i>Helicobacter pylori</i> Infection in Patients with Penicillin Allergy
by: Ligang Liu, et al.
Published: (2023-04-01) -
Review – Treatment of Helicobacter pylori infection 2023
by: M. Nkuize, et al.
Published: (2023-10-01) -
Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial
by: Chen Chen, et al.
Published: (2024-04-01) -
Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis
by: Yaobin Ouyang, et al.
Published: (2022-03-01)